
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Short-Term Adverse Effects Immediately after the Start of COVID-19 Booster Vaccination in Vietnam
Duy Cuong Nguyen, Thi Loi Dao, Thi Minh Dieu Truong, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 19
Duy Cuong Nguyen, Thi Loi Dao, Thi Minh Dieu Truong, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 19
Showing 19 citing articles:
Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh
Homayra Rahman Shoshi, Ahamed Khairul Basher, Ashrak Shad Pyash, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access
Homayra Rahman Shoshi, Ahamed Khairul Basher, Ashrak Shad Pyash, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access
Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population
Mohamed Lounis, Hani Amir Aouissi, Samir Abdelhadi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1781-1781
Open Access | Times Cited: 20
Mohamed Lounis, Hani Amir Aouissi, Samir Abdelhadi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1781-1781
Open Access | Times Cited: 20
Right Biceps Pseudo-Tumor from COVID-19 Vaccination
Anas M. Abbas, Martha Caicedo, Timothy A. Damron
Vaccines (2024) Vol. 12, Iss. 2, pp. 160-160
Open Access | Times Cited: 2
Anas M. Abbas, Martha Caicedo, Timothy A. Damron
Vaccines (2024) Vol. 12, Iss. 2, pp. 160-160
Open Access | Times Cited: 2
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System
Jung Yoon Choi, Yongjoon Lee, Nam Gi Park, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 356-356
Open Access | Times Cited: 2
Jung Yoon Choi, Yongjoon Lee, Nam Gi Park, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 356-356
Open Access | Times Cited: 2
Attitude and Acceptance towards COVID-19 Booster Doses among Literacy Advantaged Population in Pakistan: A Cross-Sectional Study
Mehmood Ahmad, Adeel Sattar, Sadaf Aroosa, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1238-1238
Open Access | Times Cited: 6
Mehmood Ahmad, Adeel Sattar, Sadaf Aroosa, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1238-1238
Open Access | Times Cited: 6
Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS)
Jieun Shin, Sung Ryul Shim, Jaekwang Lee, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 1
Jieun Shin, Sung Ryul Shim, Jaekwang Lee, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 1
Health and Well-Being through COVID-19 Vaccination: Physical, Oral, and Psychological Effects
Kelvin I. Afrashtehfar, Carlos A. Jurado, Salem Abu-Fanas, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3117-3117
Open Access | Times Cited: 3
Kelvin I. Afrashtehfar, Carlos A. Jurado, Salem Abu-Fanas, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3117-3117
Open Access | Times Cited: 3
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
Vacunas (2023) Vol. 24, Iss. 3, pp. 210-217
Open Access | Times Cited: 3
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
Vacunas (2023) Vol. 24, Iss. 3, pp. 210-217
Open Access | Times Cited: 3
Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study
Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Short-Term Adverse Effects of the Fourth Dose of Vaccination against COVID-19 in Adults over 40 Years of Age
Jussara Malo-Castillo, Harold Jiménez-Álvarez, Victor Ludeña-Meléndez, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 400-400
Open Access
Jussara Malo-Castillo, Harold Jiménez-Álvarez, Victor Ludeña-Meléndez, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 400-400
Open Access
Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination
Pattriya Jirawattanadon, Charussri Leeyaphan, Pornpan Koomanachai, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 309-309
Open Access
Pattriya Jirawattanadon, Charussri Leeyaphan, Pornpan Koomanachai, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 309-309
Open Access
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis
Farren Briggs, Hollie Schmidt, Farrah J. Mateen, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 94, pp. 106253-106253
Closed Access
Farren Briggs, Hollie Schmidt, Farrah J. Mateen, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 94, pp. 106253-106253
Closed Access
Safety Profile of Standard and Booster Covid-19 Vaccines in Physicians in Quito-Ecuador. A Cross-Sectional Study
Nancy Jeanneth Flores-Lastra, Josué Rivadeneira, Luis Fuenmayor-González, et al.
(2023)
Open Access | Times Cited: 1
Nancy Jeanneth Flores-Lastra, Josué Rivadeneira, Luis Fuenmayor-González, et al.
(2023)
Open Access | Times Cited: 1
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
Vacunas (English Edition) (2023) Vol. 24, Iss. 3, pp. 210-217
Open Access | Times Cited: 1
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
Vacunas (English Edition) (2023) Vol. 24, Iss. 3, pp. 210-217
Open Access | Times Cited: 1
Adverse Reactions with Covid-19 Vaccine Booster are of Milder Gravity than with First and Second Dose
José Luis Turabián
MedPress Public Health and Epidemiolog (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 2
José Luis Turabián
MedPress Public Health and Epidemiolog (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 2
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
ĐÁNH GIÁ TÁC DỤNG PHỤ SAU TIÊM VẮC-XIN ASTRAZENECA CHO MŨI 1 VÀ PFIZER CHO MŨI 2 TẠI CẦN THƠ NĂM 2021
Quang Hiệp Khưu, Thúy Anh Nguyễn, Phương Nam Nguyễn, et al.
Tạp chí Y Dược học Cần Thơ (2023), Iss. 61, pp. 336-342
Open Access
Quang Hiệp Khưu, Thúy Anh Nguyễn, Phương Nam Nguyễn, et al.
Tạp chí Y Dược học Cần Thơ (2023), Iss. 61, pp. 336-342
Open Access
Risk of lymphadenopathy from SARS-CoV-2 vaccination in Korea: a self-controlled case series analysis
Mi‐Sook Kim, Bongyoung Kim, Jeong Pil Choi, et al.
Epidemiology and Health (2023) Vol. 45, pp. e2023090-e2023090
Open Access
Mi‐Sook Kim, Bongyoung Kim, Jeong Pil Choi, et al.
Epidemiology and Health (2023) Vol. 45, pp. e2023090-e2023090
Open Access
Regular COVID-19 booster shot preference and willingness to pay in the Vietnamese population: a theory-driven discrete choice experiment (Preprint)
Anh Linh, Bach Xuan Tran, Laurent Boyer, et al.
(2022)
Closed Access
Anh Linh, Bach Xuan Tran, Laurent Boyer, et al.
(2022)
Closed Access